Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 carbonyl 4 [hydroxy(methyl)phosphono]butyric acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115772508B reveals high-activity DAAO mutants for efficient L-glufosinate intermediate production, offering significant cost and supply chain advantages.